To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
EN 
EL 
FR 
IT 
ES 
PT 
DE 
Intracranial cranial glioma, also known as brain glioma, refers to a type of tumour that originates in the neuroglial cells of the brain. Neuroglial cells are non-neuronal cells that provide support and protection to neurons in the brain.
Gliomas are classified by the type of neuroglial cells from which they originate, which include astrocytes, oligodendrocytes and investing cells. Common types of gliomas include astrocytomas, oligodendrogliomas and investigomas.
Symptoms and treatment options for intracranial cranial gliomas vary depending on the location, size and grade of the tumour. Common symptoms may include headaches, seizures, cognitive changes, motor deficits, and changes in behavior or personality. Diagnosis usually involves imaging tests such as an MRI or CT scan, followed by a biopsy to confirm the type and grade of glioma.
Treatment options for intracranial cranial gliomas may include surgery, radiation therapy and chemotherapy. The specific treatment approach depends on several factors, including the type, location and grade of the tumor, as well as the patient's overall health and preferences.
It is important for people with intracranial cranial gliomas to work closely with a multidisciplinary medical team, including neurologists, neurosurgeons, oncologists and other specialists, to develop a personalised treatment plan and receive ongoing care and support.